# Vortioxetine vs Sertraline in Mexicans

> **NCT03978286** · PHASE4 · COMPLETED · sponsor: **Universidad Juárez Autónoma de Tabasco** · enrollment: 21 (actual)

## Conditions studied

- Depression
- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Vortioxetine
- **DRUG:** Sertraline

## Key facts

- **NCT ID:** NCT03978286
- **Lead sponsor:** Universidad Juárez Autónoma de Tabasco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-30
- **Primary completion:** 2017-06-30
- **Final completion:** 2018-06-30
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2019-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03978286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03978286, "Vortioxetine vs Sertraline in Mexicans". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03978286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*